The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Fidelity Select Medical Tech and Devcs FSMEX
- NAV / 1-Day Return 62.02 / −1.08 %
- Total Assets 5.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.700%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Mid Growth
- Min. Initial Investment —
- Status Open
- TTM Yield —
- Turnover 37%
USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:16 PM GMT+0
Morningstar’s Analysis FSMEX
Will FSMEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 69.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Boston Scientific Corp | 14.05 | 824.3 Mil | Healthcare |
Danaher Corp | 13.72 | 805.0 Mil | Healthcare |
Thermo Fisher Scientific Inc | 9.48 | 555.9 Mil | Healthcare |
Intuitive Surgical Inc | 6.57 | 385.6 Mil | Healthcare |
Stryker Corp | 6.37 | 373.5 Mil | Healthcare |
Penumbra Inc | 4.49 | 263.5 Mil | Healthcare |
Abbott Laboratories | 4.41 | 258.6 Mil | Healthcare |
Edwards Lifesciences Corp | 4.05 | 237.6 Mil | Healthcare |
Veeva Systems Inc Class A | 3.31 | 193.9 Mil | Healthcare |
IQVIA Holdings Inc | 2.91 | 170.5 Mil | Healthcare |